Posters
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
POSTER
Characterization of a Model of Parkinson’s Disease Using Synthetic α-Synuclein Inoculation to Evaluate Motor Function, Synucleinopathy, and Dopaminergic Neurotransmission.
POSTER
The NIH HEAL Initiative Preclinical Screening Platform for Pain (PSPP) efforts to validate rodent models of pain and migraine
POSTER
The NIH HEAL Initiative Preclinical Screening Platform for Pain (PSPP) Validation of the Monoiodoacetate (MIA) Model of Osteoarthritis Pain in the Rat
POSTER
The NIH HEAL Initiative Preclinical Screening Platform for Pain Efforts to Validate Two Models of Chemotherapy-Induced Painful Neuropathy in the Rat
POSTER
Efforts to Accelerate Development of Non-Opioid, Non-Addictive Pain Therapeutics Within the NIH HEAL Initiative Preclinical Screening Platform for Pain and Validation Examples
POSTER
Characterization of the Rat MonoiodoacetateModel of Osteoarthritis: Evoked and Non-evoked Pain Response Assessments
POSTER
